M. Saar

ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe

Nathan I. Cherny, Richard Sullivan, Julie Torode et al. · Annals of Oncology · 2016 · 172 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +16

ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe

Nathan I. Cherny, Richard Sullivan, Julie Torode et al. · Annals of Oncology · 2017 · 118 citations · Full text

Public Health, Oncology, Pharmaceutical Policy +13

Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications

Nenad Miljković, Brian Godman, Milena Kovačević et al. · Frontiers in Pharmacology · 2020 · 40 citations · Full text

Management, Health Care Management, Risk Management +15

ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update

Nathan I. Cherny, Dario Trapani, M. Galotti et al. · Annals of Oncology · 2025 · 21 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +14

Suppression of Taxanes Cytotoxicity by Citrus Flavonoid Hesperetin in PPC-1 Human Prostate Cancer Cells

Katrin Sak, Helen Lust, Marju Kase et al. · Anticancer Research · 2018 · 15 citations · Full text

Medicine, Oncology, Pharmacology +15